ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $121,000 | -35.6% | 83,337 | 0.0% | 0.00% | – |
| Q4 2017 | $188,000 | -27.4% | 83,337 | +9.6% | 0.00% | – |
| Q3 2017 | $259,000 | 0.0% | 76,052 | +4.1% | 0.00% | – |
| Q2 2017 | $259,000 | +11.6% | 73,023 | +7.1% | 0.00% | – |
| Q1 2017 | $232,000 | -28.6% | 68,202 | -3.5% | 0.00% | – |
| Q4 2016 | $325,000 | -9.5% | 70,640 | -16.5% | 0.00% | – |
| Q3 2016 | $359,000 | +76.8% | 84,578 | 0.0% | 0.00% | – |
| Q2 2016 | $203,000 | +46.0% | 84,578 | +186.7% | 0.00% | – |
| Q1 2016 | $139,000 | +19.8% | 29,496 | 0.0% | 0.00% | – |
| Q4 2015 | $116,000 | +1.8% | 29,496 | 0.0% | 0.00% | – |
| Q3 2015 | $114,000 | +500.0% | 29,496 | +628.3% | 0.00% | – |
| Q2 2015 | $19,000 | -36.7% | 4,050 | -10.1% | 0.00% | – |
| Q1 2015 | $30,000 | +100.0% | 4,507 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | – | 4,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
| Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
| Family Management Corp | 10,424 | $14,000 | 0.01% |
| LMR Partners LLP | 81,550 | $110,000 | 0.01% |
| ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
| Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
| FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |